United States · FDA National Drug Code directory
Oxaprozin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0617_f128ff41-2ad3-4a5b-a34c-13d6f8940f35
- Product NDC
- 71335-0617
- Form
- TABLET
- Composition / generic term
- Oxaprozin
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170504
- Source listing expiry
- 20261231
Source-listed ingredients
- OXAPROZIN — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-0617-1) · 71335-0617-1
- 20 TABLET in 1 BOTTLE (71335-0617-2) · 71335-0617-2
- 14 TABLET in 1 BOTTLE (71335-0617-3) · 71335-0617-3
- 60 TABLET in 1 BOTTLE (71335-0617-4) · 71335-0617-4
- 90 TABLET in 1 BOTTLE (71335-0617-5) · 71335-0617-5
- 6 TABLET in 1 BOTTLE (71335-0617-6) · 71335-0617-6
- 120 TABLET in 1 BOTTLE (71335-0617-7) · 71335-0617-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →